APO-CAPECITABINE capecitabine 500 mg tablet blister pack

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

capecitabine, Quantity: 500 mg

Tillgänglig från:

Arrotex Pharmaceuticals Pty Ltd

INN (International namn):

Capecitabine

Läkemedelsform:

Tablet, film coated

Sammansättning:

Excipient Ingredients: magnesium stearate; iron oxide yellow; titanium dioxide; lactose; colloidal anhydrous silica; methylcellulose; iron oxide red; hyprolose; croscarmellose sodium; hypromellose; macrogol 8000

Administreringssätt:

Oral

Enheter i paketet:

120

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Colon Cancer,Capecitabine is indicated for the adjuvant treatment of patients with Dukes' stage C and high-risk stage B, colon cancer, either as monotherapy or in combination with oxaliplatin.,Colorectal Cancer,Capecitabine is indicated for the treatment of patients with advanced or metastatic colorectal cancer.,Oesophagogastric Cancer,Capecitabine is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen.,Breast Cancer,Capecitabine is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated.,Capecitabine in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy.

Produktsammanfattning:

Visual Identification: Peach, oval, biconvex, film-coated tablet. Engraved APO on one side, C500 on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Bemyndigande status:

Licence status A

Tillstånd datum:

2014-01-16